The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity

Molecular Microbiology

Volumn 31, Issue 5, 1999, Pages 1443-1462

  Skurnik, Mikael ^a   Venho, Reija ^a   Bengoechea, José Antonio ^a,b   Moriyón, Ignacio ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; O ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; DEFENSE MECHANISM; IMMUNITY; LIVER; MEMBRANE PERMEABILITY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; OPERON; PEYER PATCH; PRIORITY JOURNAL; SPLEEN; YERSINIA ENTEROCOLITICA;

ANIMALIA; BACTERIA (MICROORGANISMS); YERSINIA ENTEROCOLITICA;

EID: 0033022863     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1999.01285.x     Document Type: Article

References (58)

1. Al-Hendy, A., Toivanen, P., and Skurnik, M. (1991) Expression cloning of Yersinia enterocolitica O: 3 rfb gene cluster in Escherichia coli K12. Microb Pathog 10: 47-59.
2. Al-Hendy, A., Toivanen, P., and Skurnik, M. (1992) Lipopolysaccharide O side chain of Yersinia enterocolitica O: 3 is an essential virulence factor in an orally infected murine model. Infect Immun 60: 870-875.
3. Ames, G.F.-L., Spudish, E.N., and Nikaido, H. (1974) Protein composition of the outer membrane of Salmonella typhimurium: Effect of lipopolysaccharide mutations. J Bacteriol 117: 406-416.
4. Appleyard, R.K. (1954) Segregation of new lysogenic types during growth of doubly lysogenic strain derived from Escherichia coil K12. Genetics 39: 440-452.
5. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, O.D., Seidman, J.G., Smith, J.A., and Struhl, K. (1987) Current Protocols in Molecular Biology. New York: John Wiley & Sons.
6. Autenrieth, I.B., Tingle, A., Reskekunz, A., and Heesemann, J. (1992) T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect Immun 60: 1140-1149.
7. Autenrieth, I.B., Reissbrodt, R., Saken, E., Berner, R., Vogel, U., Rabsch, W., and Heesemann, J. (1994) Desferrioxamine-promoted virulence of Yersinia enterocolitica in mice depends on both desferrioxamine type and mouse strain. J Infect Dis 169: 562-567.
8. Autenrieth, I.B., Bohn, E., Ewald, J.H., and Heesemann, J. (1995) Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J Infect Dis 172: 490-496.
9. Autenrieth, I.B., Kempf, V., Sprinz, T., Preger, S., and Schnell, A. (1996) Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect Immun 64: 1357-1368.
10. Balligand, G., Laroche, Y., and Cornelis, G. (1985) Genetic analysis of a virulence plasmid from a serogroup 9 Yersinia enterocolitica strain: role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect Immun 48: 782-786.
11. Bengoechea, J.A., Díaz, R., and Moriyón, I. (1996) Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides. Infect Immun 64: 4891-4899.
12. Bengoechea, J.A., Lindner, B., Seydel, U., Díaz, R., and Moriyón, I. (1998a) Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica. Microbiology 144: 1509-1515.
13. Bengoechea, J.A., Brandenburg, K., Seydel, U., Díaz, R., and Moriyón, I. (1998b) Yersinia pseudotuberculosis and Yersinia pestis show increased outer membrane permeability to hydrophobic agents which correlates with lipopolysaccharide acyl-chain fluidity. Microbiology 144: 1517-1526.
14. de Cock, H., and Tommassen, J. (1996) Lipopolysaccharides and divalent cations are involved in the formation of an assembly-competent intermediate of outer membrane protein PhoE of E. coli. EMBO J 15: 5567-5573.
15. Díaz-Aparicio, E., Aragón, V., Marín, C., Alonso, B., Font, M., Moreno, E., Pérez-Ortiz, S., Blasco, J.M., Diaz, R., and Moriyón, I. (1993) Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol 31: 3136-3141.
16. Elass-Rochardt, E., Legrand, D., Salmon, V., Roseanu, A., Trif, M., Tobias, P.S., Mazurier, J., and Spik, G. (1998) Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun 66: 486-491.
17. Falkow, S. (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10: S274-S276.
18. Falkow, S. (1991) Bacterial entry into eukaryotic cells. Cell 65: 1099-1102.
19. Freer, E., Moreno, E., Moriyón, I., Pizzarro-Cerdá, J., Weintraub, A., and Gorvel, J.P. (1996) Brucella/Salmonella-lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides than their native Brucella spp. counterparts. J Bacteriol 178: 5867-5876.
20. Granfors, K., Lahesmaa-Rantala, R., Ståhlberg, T.H., and Toivanen, A. (1989) Comparison of bacteria with and without plasmid-encoded proteins as antigens for measurement of immunoglobulin M, G, and A antibodies to Yersinia enterocolitica by enzyme-linked immunosorbent assay. J Clin Microbiol 27: 583-585.
21. Groisman, E.A. (1994) How bacteria resist killing by host-defence peptides. Trends Microbiol 2: 444-449.
22. Gulig, P.A. (1993) Use of isogenic mutants to study bacterial virulence factors. J Microbiol Methods 18: 275-287.
23. Guo, L., Lim, K.B., Gunn, J.S., Bainbridge, B., Darveau, R.P., Hackett, M., and Miller, S.I. (1997) Regulation of lipid A modifications by Salmonella typhimurium virulence genes phop-phoq. Science 276: 250-253.
24. Hancock, R.E.W. (1984) Alterations in outer membrane permeability. Annu Rev Microbiol 38: 237-264.
25. 31P-NMR Study. Mol Microbiol 11: 481-487.
26. Helander, I.M., Kato, Y., Kilpeläinen, Y., Kostianen, R., Lindner, B., Nummila, K., Sugiyama, T., and Yokochi, Y. (1996) Characterization of lipopolysaccharides of polymyxin-resistant and polymyxin-sensitive Klebsiella pneumoniae O3. Eur J Biochem 237: 272-278.
27. Hoffman, J., Lindberg, B., and Brubaker, R.R. (1980) Structural studies of the O-specific side-chains of the lipopolysaccharide from Yersinia enterocolitica Ye 128. Carbohydr Res 78: 212-214.
28. Kurien, B.J., and Scofield, R.H. (1995) Polyethylene glycol-mediated bacterial colony transformation. Biotechniques 18: 1023-1026.
29. Loh, B., Grant, C., and Hancock, R.E.W. (1984) Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 26: 546-551.
30. Markwell, M.A.K., Haas, S.M., Bieber, L.L., and Tolbert, N.E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane lipoprotein samples. Anal Biochem 87: 206-210.
31. Martínez de Tejada, G., and Moriyón, I. (1993) The outer membranes of Brucella spp. are not barriers to hydrophobic permeants. J Bacteriol 175: 5273-5275.
32. Martínez de Tejada, G., and Moriyón, I. (1995) The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun 63: 3054-3061.
33. Michiels, T., and Cornelis, G.R. (1991) Secretion of hybrid proteins by the Yersinia Yop export system. J Bacteriol 173: 1677-1685.
34. Miller, V.L., and Mekalanos, J.J. (1988) A novel suicide vector and its use in construction of insertion mutations: Osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 170: 2575-2583.
35. Nakajima, R., Motin, V.L., and Brubaker, R.R. (1995) Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization. Infect Immun 63: 3021-3029.
36. Nedialkov, Y.A., Motin, V.L., and Brubaker, R.R. (1997) Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect Immun 65: 1196-1203.
37. Nicolas, P., and Mor, A. (1995) Peptides as weapons against microorganisms in the chemical defence system of vertebrates. Annu Rev Microbiol 49: 277-304.
38. Nikaido, H., and Vaara, M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49: 1-32.
39. Nummila, K., Kilpeläinen, I., Zähringer, U., Vaara, M., and Helander, I.M. (1995) Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coil are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol 16: 271-278.
40. Olling, S. (1977) Sensitivity of Gram-negative bacilli to the serum bactericidal activity: a marker of the host-parasite relationship in acute and persisting infections. Scand J Infect Dis 10 (suppl.): 1-40.
41. Pepe, J.C., Wachtel, M.R., Wagar, E., and Miller, V.L. (1995) Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun 63: 4837-4848.
42. Peterson, A.A., Haug, A., and McGroarty, E.J., (1986) Physical properties of short- and long-O-antigen containing fractions of lipopolysaccharide from Escherichia coli O111: B4. J Bacteriol 165: 116-122.
43. Pilz, D., Vocke, T., Heesemann, J., and Brade, V. (1992) Mechanism of YadA-mediated serum resistance of Yersinia enterocolitica serotype O3. Infect Immun 60: 189-195.
44. Radziejewska-Lebrecht, J., Shashkov, A.S., Stroobant, V., Wartenberg, K., Warth, C., and Mayer, H. (1994) The inner core region of Yersinia enterocolitica Ye75R (0:3) lipopolysaccharide. Eur J Biochem 221: 343-351.
45. Robins-Browne, R.M., and Prpic, J.K. (1985) Effects of iron and desferrioxamine on infections with Yersinia enterocolitica. Infect Immun 47: 774-779.
46. Rudbach, J.A., Milner, K.C., and Ribi, E. (1976) Hybrid formation between bacterial endotoxins. J Exp Med 126: 63-79.
47. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: a Laboratory Manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
48. Shashkov, A.S., Radziejewska-Lebrecht, J., Kochanowski, H., and Mayer, H. (1995) The chemical structure of the outer core region of the Yersinia enterocolitica O:3 lipopolysaccharide (abstract). 8th European Carbohydrate Symposium, 2-7 July 1995, Seville, Spain.
49. Simon, R., Priefer, U., and Pühler, A. (1983) A broad host range mobilization system for in vivo genetic engineering: Transposon mutagenesis in Gram negative bacteria. Biotechnology 1: 784-791.
50. Skurnik, M. (1984) Lack of correlation between the presence of plasmids and fimbriae in Yersinia enterocolitica and Yersinia pseudotuberculosis. J Appl Bacteriol 56: 355-363.
51. Skurnik, M. (1985) Expression of antigens encoded by the virulence plasmid of Yersinia enterocolitica under different growth conditions. Infect Immun 47: 183-190.
52. Skurnik, M., Venho, R., Toivanen, P., and Al-Hendy, A. (1995) A novel locus of Yersinia enterocolitica serotype O:3 involved in lipopolysaccharide outer core biosynthesis. Mol Microbiol 17: 575-594.
53. Skurnik, M., Mikkola, P., Toivanen, P., and Tertti, R. (1996) Passive immunization with monoclonal antibodies specific for lipopolysaccharide (LPS) O-side chain protects mice against intravenous Yersinia enterocolitica serotype O:3 infection. APMIS 104: 598-602.
54. Tsai, C.-M., Frasch, C., and E. (1982) A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119: 115-119.
55. Vaara, M. (1992) Agents that increase the permeability of the outer membrane. Microbiol Rev 56: 395-411.
56. Wachter, E., and Brade, V. (1989) Influence of surface modulations by enzymes and monoclonal antibodies on alternative complement pathway activation by Yersinia enterocolitica. Infect Immun 57: 1984-1989.
57. Westphal, O., and Jann, K. (1965) Bacterial lipopolysaccharides. Methods Carbohydr Chem 33: 158-174.
58. Zhang, L., and Skurnik, M. (1994) Isolation of an R M mutant of Yersinia enterocolitica serotype O:8 and its application in construction of rough mutants utilizing mini-Tn5 derivatives and lipopolysaccharide-specific phage. J Bacteriol 176: 1756-1760.